These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 38429992)

  • 21. Derivation of Transcriptomics-Based Points of Departure for 20 Per- or Polyfluoroalkyl Substances Using a Larval Fathead Minnow (Pimephales promelas) Reduced Transcriptome Assay.
    Villeneuve DL; Bush K; Hazemi M; Hoang JX; Le M; Blackwell BR; Stacy E; Flynn KM
    Environ Toxicol Chem; 2024 Feb; ():. PubMed ID: 38415853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mixtures of per- and polyfluoroalkyl substances (PFAS) alter sperm methylation and long-term reprogramming of offspring liver and fat transcriptome.
    Maxwell DL; Oluwayiose OA; Houle E; Roth K; Nowak K; Sawant S; Paskavitz AL; Liu W; Gurdziel K; Petriello MC; Richard Pilsner J
    Environ Int; 2024 Apr; 186():108577. PubMed ID: 38521043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integrating high-throughput phenotypic profiling and transcriptomic analyses to predict the hepatosteatosis effects induced by per- and polyfluoroalkyl substances.
    Luo YS; Ying RY; Chen XT; Yeh YJ; Wei CC; Chan CC
    J Hazard Mater; 2024 May; 469():133891. PubMed ID: 38457971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Legacy and alternative per- and polyfluoroalkyl substances (PFAS) alter the lipid profile of HepaRG cells.
    Kashobwe L; Sadrabadi F; Brunken L; Coelho ACMF; Sandanger TM; Braeuning A; Buhrke T; Öberg M; Hamers T; Leonards PEG
    Toxicology; 2024 Aug; 506():153862. PubMed ID: 38866127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human hepatocytes derived from pluripotent stem cells: a promising cell model for drug hepatotoxicity screening.
    Gómez-Lechón MJ; Tolosa L
    Arch Toxicol; 2016 Sep; 90(9):2049-2061. PubMed ID: 27325232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioactivity profiling of per- and polyfluoroalkyl substances (PFAS) identifies potential toxicity pathways related to molecular structure.
    Houck KA; Patlewicz G; Richard AM; Williams AJ; Shobair MA; Smeltz M; Clifton MS; Wetmore B; Medvedev A; Makarov S
    Toxicology; 2021 Jun; 457():152789. PubMed ID: 33887376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of in vitro methods in assessing human health risks associated with short-chain perfluoroalkyl and polyfluoroalkyl substances (PFAS).
    Solan ME; Lavado R
    J Appl Toxicol; 2022 Aug; 42(8):1298-1309. PubMed ID: 34873727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison on the mechanism and potency of hepatotoxicity among hemp extract and its four major constituent cannabinoids.
    Gao X; Campasino K; Yourick MR; Zhao Y; Sepehr E; Vaught C; Sprando RL; Yourick JJ
    Toxicology; 2024 Aug; 506():153885. PubMed ID: 39004335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of 147 perfluoroalkyl substances for immunotoxic and other (patho)physiological activities through phenotypic screening of human primary cells.
    Houck KA; Friedman KP; Feshuk M; Patlewicz G; Smeltz M; Clifton MS; Wetmore BA; Velichko S; Berenyi A; Berg EL
    ALTEX; 2023; 40(2):248–270. PubMed ID: 36129398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcriptomic re-analyses of human hepatocyte spheroids treated with PFAS reveals chain length and dose-dependent modes of action.
    Barutcu AR; Black MB; Andersen ME
    Toxicol Appl Pharmacol; 2024 Aug; 489():117013. PubMed ID: 38936668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A review of omics-based PFAS exposure studies reveals common biochemical response pathways.
    Beale DJ; Sinclair GM; Shah R; Paten AM; Kumar A; Long SM; Vardy S; Jones OAH
    Sci Total Environ; 2022 Nov; 845():157255. PubMed ID: 35817100
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro evaluation of the carcinogenic potential of perfluorinated chemicals.
    Vaccari M; Serra S; Ranzi A; Aldrovandi F; Maffei G; Mascolo MG; Mescoli A; Montanari E; Pillo G; Rotondo F; Scaroni I; Vaccari L; Zanzi C; Fletcher T; Paparella M; Colacci A
    ALTEX; 2024; 41(3):439-456. PubMed ID: 38652827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Moving beyond the comprehensive in vitro proarrhythmia assay: Use of human-induced pluripotent stem cell-derived cardiomyocytes to assess contractile effects associated with drug-induced structural cardiotoxicity.
    Yang X; Papoian T
    J Appl Toxicol; 2018 Sep; 38(9):1166-1176. PubMed ID: 29484688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Grouping of UVCB substances with dose-response transcriptomics data from human cell-based assays.
    House JS; Grimm FA; Klaren WD; Dalzell A; Kuchi S; Zhang SD; Lenz K; Boogaard PJ; Ketelslegers HB; Gant TW; Rusyn I; Wright FA
    ALTEX; 2022; 39(3):388–404. PubMed ID: 35288757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Grouping of UVCB substances with new approach methodologies (NAMs) data.
    House JS; Grimm FA; Klaren WD; Dalzell A; Kuchi S; Zhang SD; Lenz K; Boogaard PJ; Ketelslegers HB; Gant TW; Wright FA; Rusyn I
    ALTEX; 2021; 38(1):123-137. PubMed ID: 33086383
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of perfluoroalkyl substances (PFAS) and PFAS mixtures on lipid metabolism in differentiated HepaRG cells as a model for human hepatocytes.
    Sadrabadi F; Alarcan J; Sprenger H; Braeuning A; Buhrke T
    Arch Toxicol; 2024 Feb; 98(2):507-524. PubMed ID: 38117326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of bioavailability and protein binding of four anionic perfluoroalkyl substances in cell-based bioassays for quantitative in vitro to in vivo extrapolations.
    Qin W; Henneberger L; Huchthausen J; König M; Escher BI
    Environ Int; 2023 Mar; 173():107857. PubMed ID: 36881956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A nonalcoholic fatty liver disease model in human induced pluripotent stem cell-derived hepatocytes, created by endoplasmic reticulum stress-induced steatosis.
    Parafati M; Kirby RJ; Khorasanizadeh S; Rastinejad F; Malany S
    Dis Model Mech; 2018 Sep; 11(9):. PubMed ID: 30254132
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Legacy and Emerging Per- and Polyfluoroalkyl Substances: Analytical Techniques, Environmental Fate, and Health Effects.
    Brase RA; Mullin EJ; Spink DC
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33498193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prenatal exposures to per- and polyfluoroalkyl substances and epigenetic aging in umbilical cord blood: The Healthy Start study.
    Niemiec SS; Kechris K; Pattee J; Yang IV; Adgate JL; Calafat AM; Dabelea D; Starling AP
    Environ Res; 2023 Aug; 231(Pt 2):116215. PubMed ID: 37224946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.